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description, the ‘NaCl’ groups should not be considered
as the control, and ‘FþV’ seems like placebo with 5-year
observation.
The long-term follow-up of the MDRD study revealed the
risk of the low-protein diet,3 which has been believed to be
good for CKD by both patients and health professionals
for a long time. The interesting hypothesis of Goraya et al. could
have been an alternative dietary intervention for CKD
patients if proven appropriately. Disappointingly, the serious
suspicion of faking research has made a mess of the series of
their RCTs.
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The Authors Reply: We thank Dr Obi et al. for their
comment1 regarding similarities in subject groups in our two
Kidney International publications2,3 and their question of
whether the two studies are truly randomized controlled
studies given that some groups across the studies are very
similar. Since 1999 we serially recruited subjects with
hypertensive nephropathy and various estimated glomerular
ﬁltration rate (eGFR) levels to test the hypothesis that dietary
acid reduction reduces acid retention,4 reduces kidney injury,2
and slows eGFR decline.3 Subjects were recruited and serially
entered into protocols designed to test these hypotheses. The
ﬁrst protocol randomized three sets of subjects with stage 2
eGFR, each of whom underwent three serial stages of studies
to assess the effect of dietary acid reduction on acid retention
(baseline and after 30 days), kidney injury (before and after
30 days), and, after a 30-day washout, the effect on eGFR after
5 years. Each subject was followed up in excess of 5 years, but
in each case the follow-up began at recruitment and study
entry. Speciﬁcally, they were not recruited as a group and then
followed as a group at the same time. We initially submitted
one manuscript to Kidney International that included the
described three serial stages of study done on each subject to
test all the three hypotheses. The Editors asked that we not
test all the three hypotheses in a single manuscript, but to do
so in separate manuscripts. We chose ﬁrst to submit a
manuscript detailing the main, randomized protocol in these
stage 2 subjects that showed long-term (5-year) effects on
eGFR3 followed by separate submissions of the shorter-term
portions of this protocol in many of the same subjects that
examined the effects on acid retention4 and, most recently,
kidney injury.2 Consequently, some subject groups that were
randomized for the 5-year protocol to examine the effects of
the interventions on eGFR were the same groups used to test
the two remaining hypotheses as described but were not
further randomized.
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Table 1 | Common patient characteristics quoted from the reports by Goraya et al.1 and Mahajan et al.2
Goraya et al.,
CKD2 control
(n=40)
Mahajan
et al., NaCl
(n=40)
Goraya et al.,
CKD2 and HCO3
(n=40)
Mahajan
et al., NaHCO3
(n=40)
Goraya et al.,
CKD2 and F+V
(n=40)
Mahajan
et al., placebo
(n=40)
Males (%) 47.5 48 47.5 48 47.5 48
Black/white/Hispanic (%) 62.5/22.5/15.0 63/23/15 62.5/20.0/17.5 63/20/18 62.5/25.0/12.5 63/25/13
Age (years) 51.5±8.3 51.5±8.3 51.2±8.2 51.2±8.2 51.3±8.5 51.3±8.5
Systolic BP (mm Hg) 134.3±8.3 152.6±14.7 134.1±5.8 155.3±12.6 133.7±8.6 155.2±12.9
eGFR (ml/min) 75.6±6.5 75.6±6.5 75.3±6.1 75.3±6.1 75.6±6.2 75.6±6.2
Plasma total CO2 (mmol/l) 26.0±0.8 26.4±0.8 25.9±0.6 26.2±0.7 25.9±0.8 26.0±0.9
PRAL (mmol/day) 59.3±21.1 59.3±21.1 64.3±17.7 64.3±17.7 60.4±19.4 60.4±19.4
8-h NAE (mEq) 24.6±5.7 24.8±6.4 24.8±5.6 24.8±5.6 24.6±5.0 24.0±5.6
Ualb (mg/g Cr) 413.6±147.9 413.6±147.9 419.3±150.8 419.3±150.8 422.2±151.6 422.2±151.6
UNAG (U/g Cr) 2.7±0.4 2.6±0.5 2.7±0.4 2.7±0.4 2.7±0.7 2.7±0.7
UET-1 (ng/g Cr) 5.5±1.1 5.7±0.8 5.7±1.0 5.7±1.0 5.5±1.2 5.5±1.2
Urine Na+ excretion (mmol/g Cr) 71.6±7.9 70.6±10.2 70.9±10.2 70.9±10.2 73.0±9.5 73.0±9.5
Urine K+ excretion (mmol/g Cr) 38.6±5.5 38.2±6.2 41.1±6.1 41.1±6.1 39.5±6.6 39.5±6.6
Abbreviations: BP, blood pressure; CKD, chronic kidney disease; Cr, creatinine; eGFR, estimated glomerular filtration rate; F+V, fruits and vegetables; NAE, net acid excretion;
PRAL, potential renal acid load; Ualb, urine albumin-to-creatinine ratio; UET-1, urine endothein-1-to-creatinine ratio; UNAG, urine N-acetyl-b-D-glucosaminidase-to-creatinine ratio.
Values are expressed as number, percentage, or mean±SD as appropriate.
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